Inside the pancreas: Progress and challenges of human beta cell mass quantification

Diabetologia

Volumn 57, Issue 5, 2014, Pages 856-859

  Tiedge, Markus ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Beta cell mass; GLP 1; Radiotracer; SPECT

Indexed keywords

EXENDIN 3 IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; HELOSPECTIN I; INDIUM; PEPTIDE;

AUTORADIOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORPHOMETRICS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; DIAGNOSTIC USE; FEMALE; MALE; PROCEDURES; SCINTISCANNING;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INSULIN-SECRETING CELLS; MALE; PEPTIDES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84898597888     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3206-z     Document Type: Review

References (25)

1. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A (2006) In vivo imaging of islet transplantation. Nat Med 12:144-148 (Pubitemid 43050090)
2. Toso C, Vallee JP, Morel P et al (2008) Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 8:701-706 (Pubitemid 351287550)
3. Medarova Z, Moore A (2009) MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol 5:444-452
4. Medarova Z, Moore A (2009) MRI in diabetes: first results. AJR Am J Roentgenol 193:295-303
5. Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908-916
6. Freeby M, Goland R, Ichise M, Maffei A, Leibel R, Harris P (2008) VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab 10(Suppl 4):98-108
7. Freeby M, Ichise M, Harris PE (2012) Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas. Islets 4:393-397
8. Schmitz A, Shiue CY, Feng Q et al (2004) Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. Nucl Med Biol 31:483-491 (Pubitemid 38490748)
9. Ueberberg S, Meier JJ, Waengler C et al (2009) Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo. Diabetes 58:2324-2334
10. Wild D, Macke H, Christ E, Gloor B, Reubi JC (2008) Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 359:766-768
11. Brom M, Joosten L, Oyen WJ, Gotthardt M, Boerman OC (2012) Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas. Contrast Media Mol Imaging 7:160-166
12. Brom M, Andralojc K, Oyen WJ, Boerman OC, Gotthardt M (2010) Development of radiotracers for the determination of the beta-cell mass in vivo. Curr Pharm Des 16:1561-1567
13. Reiner T, Thurber G, Gaglia J et al (2011) Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci U S A 108:12815-12820
14. Wild D, Wicki A, Mansi R et al (2010) Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 51:1059-1067
15. 18F]exendin (9-39) as a potential biomarker to measure pancreatic beta-cell mass. Nucl Med Biol 39:167-176
16. 40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med 54:244-251
17. 40-exendin-4 by targeting GLP-1 receptor. Bioconjug Chem 22:1587-1594
18. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 37:1345-1355
19. 111In-exendin. Diabetologia. doi: 10.1007/s00125-014-3166-3
20. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32-42
21. Xu G, Kaneto H, Laybutt DR et al (2007) Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 56:1551-1558 (Pubitemid 46842610)
22. Korner M, Stockli M, Waser B, Reubi JC (2007) GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736-743 (Pubitemid 47604973)
23. Oram R, Jones A, Besser RJ et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187-191
24. Madsen MT (2007) Recent advances in SPECT imaging. J Nucl Med 48:661-673 (Pubitemid 47571425)
25. Faustman DL (2014) Why were we wrong for so long? The pancreas of type 1 diabetic patients commonly functions for decades. Diabetologia 57:1-3